Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1114-7. doi: 10.1016/j.bmcl.2009.12.023. Epub 2009 Dec 6.

Abstract

Preclinical studies suggest that compounds with dual norepinephrine reuptake inhibitor (NRI) and 5-HT(1A) partial agonist properties may provide an important new therapeutic approach to ADHD, depression, and anxiety. Reported herein is the discovery of a novel chemical series with a favorable NRI and 5-HT(1A) partial agonist pharmacological profile as well as excellent selectivity for the norepinephrine transporter over the dopamine transporter.

Publication types

  • Comparative Study

MeSH terms

  • Adrenergic Uptake Inhibitors / chemical synthesis*
  • Adrenergic Uptake Inhibitors / metabolism
  • Adrenergic Uptake Inhibitors / pharmacology
  • Cell Line
  • Crystallography, X-Ray
  • Drug Design*
  • Drug Evaluation, Preclinical / methods
  • Humans
  • Microsomes, Liver / drug effects
  • Microsomes, Liver / metabolism
  • Norepinephrine Plasma Membrane Transport Proteins / antagonists & inhibitors*
  • Norepinephrine Plasma Membrane Transport Proteins / metabolism
  • Phenols / chemical synthesis
  • Phenols / metabolism
  • Phenols / pharmacology
  • Pyridines / chemical synthesis*
  • Pyridines / metabolism
  • Pyridines / pharmacology
  • Receptor, Serotonin, 5-HT1A / metabolism
  • Serotonin 5-HT1 Receptor Agonists*
  • Serotonin Receptor Agonists / chemical synthesis*
  • Serotonin Receptor Agonists / metabolism
  • Serotonin Receptor Agonists / pharmacology

Substances

  • Adrenergic Uptake Inhibitors
  • Norepinephrine Plasma Membrane Transport Proteins
  • Phenols
  • Pyridines
  • Serotonin 5-HT1 Receptor Agonists
  • Serotonin Receptor Agonists
  • Receptor, Serotonin, 5-HT1A
  • phenoxy radical